Health Economist

Key Information

Salary
:
Commencement on the salary range is subject to comparable skills and experience.

Reporting to
:
Professor Axel Behrens

Accountable to
:
Dr Patrick Kierkegaard

Duration of contract
:
Fixed Term for 2 years (with possibility of extension)

Hours per week
: 35 hours per week (Full Time)

Location
:
Chelsea

Closing Date
: 16th February 2026

This role is eligible for ICR Sponsorship. If this is your first visa in the UK, support will be provided for costs associated with Visa application. If you are considering relocating to the UK, further information can be found here. As this is a UK‑based position, the successful applicant will be required to hold permanent UK residency upon appointment.

Under the guidance of Cancer Technology Catalyst team lead Dr Patrick Kierkegaard, we are seeking to recruit a Health Economist to pioneer evaluations at the CRUK Convergence Science Centre. Based in South Kensington, London, with travel to partner sites (The Royal Marsden NHS Foundation Trust, ICR Sutton, Imperial College Healthcare NHS Trust).

The successful candidate will lead early-stage health economic modelling and health technology assessment (HTA) for cutting‑edge oncology innovations, including precision drugs, diagnostics, treatments, clinical guidelines, and digital health technologies (DHTs).

The Cancer Research UK Convergence Science Centre (CSC) is a partnership between Imperial College London and The Institute of Cancer Research (ICR) with funding from Cancer Research UK. Convergence research is driven by a societal need and utilises a deep integration across disciplines. Professor Axel Behrens is the Scientific Director of the CRUK Convergence Science Centre.

This position of Health Economist is integrated within our Cancer Technology Catalyst team (CTC). The CTC is an initiative designed to expedite the journey of promising cancer technologies from concept to clinical impact. Led by a diverse team of experts, the CTC is committed to unlocking the full potential of innovative solutions and addressing the challenges inherent in bringing them to patients.

By harnessing a collaborative Team Science approach, the CTC works closely with Principal Investigators and their teams to develop comprehensive evidence packages that not only inform robust value propositions for cancer technologies, but also strategically position them for successful clinical integration.

Please see the attached job description for essential skills and qualifications for this role, and further information.

• A dynamic and supportive research environment
• Access to state‑of‑the‑art facilities and professional development opportunities
• Collaboration with leading researchers in the field
• Competitive salary and pension

The ICR is committed to supporting overseas applicants applying for roles, please  to find out further information.

The Institute of Cancer Research, London, is one of the world's most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. Further information about working at the ICR can be found here.

As a member of staff, you'll have exclusive access to a range of staff benefits.

We champion diversity as we believe it fuels innovation and drives impactful research. We welcome applicants from all walks of life, valuing diverse perspectives that enrich our work.

We are committed to being an equal opportunity for all, regardless of ethnicity, gender, age, sexual orientation, disability, or any other dimension of diversity. Join us in creating an inclusive environment where everyone's voice is heard and valued.

For an informal discussion regarding the role, please contact Patrick Kierkegaard via p.